Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They don't need an audit to file annual financials. However, it would behoove POTN to post a 2018 audited statement to be able to uplist efficiently.
The TRUTH is accumulation is happening.
.003s soon.
MASSIVE accumulation in the low .002s.
.003s coming FAST.
Fills taking place @ .0021, .003s on their way.
Incorrect, at least 10%.
I don't follow. Your logic is that POTN will never hit $1.00, because they have 0 inventory? That's absurd.
Clearly POTN is working with some wholesaler or vendor of CBD, to which they are licensed to put their packaging / marketing information on a product and sell it.
In terms of financials - all this does is increase their COGS on an income statement rather than carry an inventory line item on the balance sheet. It's rather irrelevant and this business model has clearly been working for POTN over the course of the last 15 months.
Gotcha, I think I misread - thanks for clarifying. And I agree, at this stage the only thing POTN is missing for uplist would be the full 2 years of audited financials.
I didn't know that Annuals were due by the end of Q1 the following year, thanks Rain and Billy.
Dude - do you know when a quarter ends? Q1 2019 ends 3/31.
POTN is not required to post their Q1 2019 earnings until 45 days after quarter end, which would be the middle of May at the latest. Hopefully they post sooner.
If you are referring to a Q4 2018, POTN is not required to post that. They are required to post a 2018 annual statement, which unfortunately on OTCmarkets.com, does not have a "due by" date.
Per the last 2 years, POTN tends to post their annual statements around this time through the first two weeks of April.
So should I buy 10M shares now? We think BANGI is going to actually be profitable / cash flow positive in a year or 2, considering all the debt and mess they are going to inherit from COBI?
Both posts very helpful, thank you
Can someone give me the reader's digest version here?
BANGI came in and bought this POS company, so that they had platform to be listed on an exchange?
Now BANGI is planning to have a business model to own properties and lease them to MJ/Hemp cultivators?
Sound about right?
Appreciate your take.
I've got some exposure to RSHN now and am thinking about increasing it dramatically. Part of me says to wait until the business plan is more flushed out, the other part of me says get in now as when the business plan does come together, we'll have already experienced the exponential growth.
Could you explain the talk of an IPO? Is that a theoretical IPO of a merged WSRC / RSHN / GRPS? Or only between RSHN / GRPS?
I get further confused when I read RSHN's shareholder update posted in January... they go on to discuss "participating companies" such as Rhamnolipid Inc, TKS Solutions, GreatRateFreight ...
Do they have an ownership stake in these participating companies, are they wholly owned, it's unclear how it's all supposed to shake out.
Help me understand the full picture here, as it's a pretty intricate web...
I've been going through the last posted financial statements for RushNet (RSHN), Gold River (GRPS), and Western Sierra (WSRC). All three companies are very interconnected, but I don't understand who stands to actually gain here? What I can surmise is below.
The Western Sierra Story:
- In June 2014, WSRC acquired $40.5M worth of water rights in Northern Colorado. From that point on, WSRC didn't do much until September 2018.
- September 2018, WSRC acquires a 100% stake of Western Colorado Farming Initiatives (WCFI) a private LLC. WCFI had already been cultivating a 15 acre hemp farm, expected to yield about 20,000~ pounds of flower. WCFI also already the ability to process and extract CBD from this hemp acreage.
- October 2018, WSRC projects the hemp farm to produce 12 month revenues of $15.6M. This is from harvest to CBD extraction.
The RushNet / GRPS Story:
- In August 2018, both RSHN and GRPS each acquired a 12.5% stake in WSRC's 15 acre hemp farm as well as $40.5M water rights. The financing from both RSHN and GRPS allowed WSRC to complete the 15 acre farm deal the following month.
- RSHN and GRPS each stand to reap 12.5% of WSRC's 12 month forecasted revenue ($15.6M), is this correct?
- RSHN's business model will essentially revolve around CBD infused drinks. "Knockout Punch", Awater, Ewater, Cwater, etc. These products are not yet readily available.
- GRPS's business model will seem to mostly revolve around CBD edibles. Pancake / waffle syrup, cookies .. but also CBD water.
- Neither company currently produces a product or generates revenue.
- RSHN has 7.7B shares outstanding. GRPS has 940M~ shares outstanding.
- RSHN and GRPS's "Business of Issuer" statements on their Q3 2018 statements are word for word exact. This is odd.
- Richard Goulding is a director for both RSHN and GRPS. While each company still has a different CEO. RSHN = Frank Deangelo ... GRPS = Stuart Miller.
Is that the full picture regarding these 3 companies? I understand RSHN and GRPS have additional ventures on the side (great freight, etc) .. but does the above explain the relationship between WSRC, RSHN, and GRPS?
KGKG mentions once during Q4 that their revenues are up 400% over Q3 .. but in terms of PPS, that is already baked in, wouldn't you think?
Glad we are starting a discussion on this!
Projected revenues are not booked revenues. Let's look at what 2018 revenues should look like for both companies:
VATE: $321,700~
KGKG: $94,600~
Based on 2018, VATE is already booking 3X the revenue of KGKG.
KGKG can PR as many different updates/projections that they would like, but the reality is what is inside the financial statements.
Yes, you are correct, these new products from VATE won't be baked in until Q2 2019 and to that end and your point, yes - that will allow us to better understand and forecast VATE's future growth.
Yes, Risi's LinkedIn profile is unclear whether he is VATE full time or part time. Though that again, is irrelevant to me as long as VATE's quarterlies continue to outpace KGKG's, which is the current case.
My point is just that based on current available financial data - VATE is still the superior company and/or investment option.
Again though- that's a blanket statement that you, or I for that matter, cannot verify to be true or not.
Risi's date of hire, per the PR, was 10/25. Since we haven't seen the year-end annual statement for 2018, we have no idea if he was able to make an impact on Q4 revenues. To that end, we also don't know if he was able to impact Q1 2019 revenues yet.
While I'd agree with you that they don't have a "sales team" in a traditional sense - you'd also have to agree that you don't know what financial impact, if any, good or bad, that Risi has had to date.
Ultimately, we are splitting hairs here and the proof is in the pudding.
VATE has stronger revenues, less shares, QB status, and smaller debt than KGKG. That's not conjecture, that's fact when reviewing each respective company's financial statements.
But what do signed distribution deals matter, if the sales track record isn't present?
I guess what I'm arguing is that I don't necessarily care how many distributors a company has, if their sales aren't there. For arguments sake , let's use the latest Q3 filing- VATE made $80K in the quarter, KGKG made $31K. Why should I care if KGKG has a dozen distributors and VATE only has one? VATE is clearly getting more product out of the door.
Your points below aren't sufficient enough to demonstrate that KGKG is a stronger/better company. VATE has a sales team, VATE has products available for sale and in fact, based on available quarterly financial data - VATE's team does a better job in both segments.
I've really never understood how KGKG manages to maintain a higher PPS, when the fundamentals of VATE are stronger. One would only have to look at the last couple financial quarters of both companies to see that VATE is a healthier, more well rounded firm.
VATE has: higher revenues, less shares, QB status, easily manageable/little debt.
Agreed - we will not see the CBD Iced Tea and Coffee sales impact until the Q2 report, which will be out around August 15th. (45 days from the quarter end in June).
However, it will be good to see the annual report VATE publishes, as then we can see the complete YoY growth with only the hemp coffee, teas, tinctures, creams, etc. I think that will allow us to establish a healthy baseline, heading into the real 2019 money maker, which is CBD.
I expect to see expenses increased in both the annual and Q1 2019 report, as the ramp up for CBD expansion could be significant. However, my gut tells me that the sales will be well worth the initial start up cost.
In addition, if these products prove to be as successful as we all hope - we will be getting new flavors of the CBD Iced Tea and who knows, maybe we get flavor iterations of the CBD coffee as well.
My long term outlook here continues to be strong. If these CBD beverages can indeed take off, if share structure can remain non-dilutive, and if VATE can get cash flow positive in Q2 & beyond this year ... we'll have ourselves the recipe to a very robust fiscal 2019.
It's been literally one business day since the launch. Relax.
Maybe we get something at the end of the week, maybe we don't. In any event, it really doesn't matter. The proof is in the pudding, which will be the quarterly financials - mainly Q2 and on.
Sit back, open a bottle of some CBD Iced Tea, and relax.
LOL this company is, has been, and always will be - a complete and utter dumpster fire.
Well said, great post. This is what I have been trying to articulate in my posts.
As I've said here before, the proof is in the pudding, and that's going to be in VATE's Q2 and Q3 2019 reports.
The launch of these new products is fantastic, but its the $$'s derived that ultimately matters.
They can always produce a teaser PR in a couple weeks on how the pre-sale of the CBD Tea has gone, but the reality is, the real show is going to be when those reports are posted.
I for one am happy to sit back and enjoy the ride between .032~ and .05~, load where applicable, and wait for the gains I'm expecting.
Ahh, the CBD Tea is here! $39 for a 12 pack, so $3.25 a bottle. Not awful considering the product is just launching and they need economies of scale to get costs down. As a reference point, Honest Tea (owned by Coca Cola, but I still think is one of the more 'premium' tea brands) is roughly $20.00 a 12 pack (depending on flavor), or $1.67 a bottle.
What grinds my gears is the shipping! First off, the only options for the product in my area is 2-day priority mail at $34.02 or 1-day priority mail express at $91.81. The cost of the 2-day mail is nearly the same as the product. I understand it's heavy, but geeze.
Choosing the cheaper shipping option brings me to a total of $73.02 or $6.08 per bottle. Awfully expensive stuff at that point.
I'm still very interested in getting my hands on some product, but I'll wait until its on Amazon or in a local bespoke/national grocer.
Couldn't agree more with you. Everything you've listed out is exactly why I'm very optimistic for the rest of 2019 and beyond.
It sure will. I can still understand that some folks are still bitter if they got in during that late Dec '17 and Jan '18 run up to the 14 cent area.. however, I think the the company is significantly more mature than it was over a year ago and they've really set themselves up nicely to hit and more important, maintain, those levels going forward.
Ha, that would be a 3 fold increase from 2018! While I'd love to see it, I'm always a bit more cautious when it comes to projections.
A case for VATE:
***Since March 4th, we've seen VATE's share price increase by 28.42%.
***Since March 5th, which was the Chexpo announcement, we saw trading volumes increase day over day. Rallying from a low of 1.972M, peaking last Friday at 7.367M. Average daily volume since the 5th has been just about 4.5M shares.
***CBD Tea taking pre-orders starting this Friday, March 15th.
***CBD RTD Coffee starting sales on April 5th.
***Successful existing hemp coffee product line, continuing to sell well in North America.
I really think VATE is progressing nicely and executing their business plan well. They are not biting off more than they can chew at any one time and have staggered their product launches effectively to create an extended period of company buzz/promotion, as well as to ensure that they do not hit a manufacturing bottleneck.
In my opinion, if both products are as successful as we want them to be, it sets up VATE nicely for exponential growth and expansion. We should see the financial impact of the initial launch in VATE's Q2 2019 report and what may be even more telling is their Q3 report, which will have re-order sales figures.
All in all, VATE had total revenues of $144.7K in 2017. In 2018, total revenue should be right around $321K. While we dont have the Q1 2019 report yet to help project, with these new products, I'm anticipating 2019 revenue comes in at $500K or more.
With all of these considerations, coupled with share structure being held in control as well as the company becoming cash flow positive, VATE is in the drivers seat for a really exciting 2019 and beyond.
WHY YOU CAN MAKE A LEGITIMATE CASE FOR VATE:
2017 total revenue: $144.7K
2018 expected (smoothed) total revenue: $321.8K
YoY is well over 100% in terms of total rev. Each quarter in 2018, VATE has gotten closer to being cash flow positive. They've been able to achieve that with a limited coffee product range and little shelf visibility. Both have changed dramatically as of today.
Share count:
EOY 2017 share count was 578.8M
Per Q3 2018 report, share count was reduced to 422.38M
Per OTCmarkets on 3/1/19, share count is 449.8M
I'D HARDLY CALL THAT DILUTION
With these new hot products coming out over the next month, I think we will see robust growth from Q2 2019 through EOY 2019.
Stay long and reap the benefits of long term capital gains.
OFFICIAL.
CBD Iced Tea pre-orders starting March 15th.
CBD RTD Coffe for sale April 5th.
We should really see the impact of these two new products in the Q2 2019 report. Let's hope it hits!
Well that was my point in my earlier post, why I'm waiting at least 6 months after the RTD drinks are released to see how successful they are.
Distribution deals are great. More product on shelves in different locations is great. Though, at the end of the day, none of that matters if it's not reflected in the total revenue numbers!
Thanks for the share. So to your point, the demand is clearly there for VATE's existing products and hopefully the new RTD beverages follow suit.
To that end and your other point, their ability to scale is next in focus. I think that's why their full acquisition of Blessed Bean, rather than the partnership, makes sense. They should be able to control their inventory levels better for all things coffee.
You nailed it. From my seat, even with the pre-orders starting next Friday the 15th - I really don't think we are going to see it's real financial impact for another 6 months or so and from there, we can better understand VATE's success trajectory.
The reason behind that is once both of the products are in the market there are questions that need to be answered: Are the products well received? If so, can VATE meet demand? If they aren't, how will VATE pivot? If the CBD iced tea's and coffees are well received, will we see repeat sales orders from the same initial purchasers? Will VATE get product on shelves in even more locations?
A successful launch is vitally important and takes careful planning and time to execute. Shareholders need to stay mindful of that and VATE's long term plan.
Not sure if you have ever run a business, let alone one like VATE with complicated logistics (I sure haven't). But for a company of this size, it takes a great deal of time to bring net new products to market. Once the product itself is finalized - making flavor additions, can/bottle design changes, etc - those can have quicker turnaround time, but it's that first initial run that takes a great deal of planning.
For both the iced tea and coffee lines there is multiple trial and errors to get the taste and ingredient formula down, the initial size of bottle and marketing design, lining up suppliers to meet those specs, lining up distributors to sell it, etc.
Every time an iteration or a change is made, that process has to effectively start over and when you are working as a small business, it just takes a great deal of time.
Since we have money invested here it quite simply will never be fast enough for the average person. But with careful implementation, scale is possible, and then we reap the rewards.
Next Friday is the day, nice. Hoping to order at least a 6 pack to start!
YOU ARE THE ANSWER TO MY QUESTIONS INTO POTNS FUNDAMENTAL FINANCIAL INDICATORS. WITHOUT YOUR CONTRIBUTIONS I WOULD HAVE ENDED UP BROKE AND ON THE STREETS. I CANNOT THANK YOU ENOUGH IN TURNING AROUND MY INVESTMENT PORTFOLIO.
THANK YOU
I APPRECIATE YOUR INFORMATIVE INSIGHT INTO POTN. IT IS POSTS LIKE THESE THAT MAKE ME QUESTION MY SIZABLE POSITION IN THIS STOCK. HOW COULD I HAVE NOT SEEN THIS SOONER. PLEASE CONTINUE TO LEAD ME TO GREENER PASTURES, YOU ARE A GODSEND TO ALL OF US HERE.
IF I GET OUT NOW, MAYBE I CAN SEW MY POCKETS BACK ON.
THANK YOU
my time horizon is loooooooooooooooooooooooooooooooooooooooong
:)